Publication related to RSI or an RSI staff member

Determinants of influenza non-vaccination among Canadian children: insights from a nationwide survey.

BACKGROUND: To identify determinants influencing Canadian parents’ decision not to vaccinate their children aged 6 months to 17 years against seasonal influenza. METHODS: Data from the 2022 Childhood COVID-19 Immunization Coverage Survey, a national survey of approximately 10,500 Canadian parents/guardians and their children, was analyzed. The survey examined influenza vaccine coverage, parental perspectives on vaccines, reasons for hesitancy, and factors influencing immunization. Socio-demographic characteristics, including ethnicity, household income, working sector, educational attainment, and prevalence of chronic medical conditions among children were considered. Historical vaccine uptake and the impact of the COVID-19 pandemic on immunization decisions were also reviewed. Key determinants of non-vaccination in the 2021-2022 influenza season were analyzed using multivariable logistic regression, with a statistical significance level set at p-value <0.05. RESULTS: 70% of children aged 6 months to 17 years did not receive the seasonal influenza vaccine. Key predictors for non-vaccination included: residing in rural settings (aOR 1.35, 95% CI 1.13-1.60), parental education attainment of less than high school (aOR 2.48, 95% CI 1.24-4.97), and the absence of chronic medical conditions in children (aOR 1.60, 95% CI 1.34-1.91). Other strong predictors included lower household income; deterrence due to the COVID-19 pandemic; and parental hesitancy stemming from concerns about the vaccine's safety, effectiveness, and by beliefs that their child was not at risk of contracting the influenza or severe consequences from the infection. CONCLUSION: This research underscores pivotal determinants of parental decisions not to vaccinate their children against seasonal influenza and sheds light on the impact of the COVID-19 pandemic. The results highlight the importance of addressing safety concerns and providing clear information to alleviate hesitancy.

Authors

  • Alami, Abdallah, Alami A, Vaccine Coverage and Effectiveness Surveillance Division, Infectious Diseases and Vaccination Programs Branch, Public Health Agency of Canada, Ottawa, ON, Canada.

  • Dave, Sailly, Dave S, Vaccine Coverage and Effectiveness Surveillance Division, Infectious Diseases and Vaccination Programs Branch, Public Health Agency of Canada, Ottawa, ON, Canada.

  • Uhlik, Caren, Uhlik C, Vaccine Coverage and Effectiveness Surveillance Division, Infectious Diseases and Vaccination Programs Branch, Public Health Agency of Canada, Ottawa, ON, Canada.

  • Ebrahim, Marwa, Ebrahim M, Vaccine Coverage and Effectiveness Surveillance Division, Infectious Diseases and Vaccination Programs Branch, Public Health Agency of Canada, Ottawa, ON, Canada.

  • Krewski, Daniel, Krewski D, School of Epidemiology and Public Health, Faculty of Medicine, University of Ottawa, Ottawa, ON, Canada.

  • Laroche, Julie, Laroche J, Vaccine Coverage and Effectiveness Surveillance Division, Infectious Diseases and Vaccination Programs Branch, Public Health Agency of Canada, Ottawa, ON, Canada.

YEAR OF PUBLICATION: 2024
SOURCE: Front Public Health. 2024 Jun 5;12:1400782. doi: 10.3389/fpubh.2024.1400782. eCollection 2024.
JOURNAL TITLE ABBREVIATION: Front Public Health
JOURNAL TITLE: Frontiers in public health
ISSN: 2296-2565 (Electronic) 2296-2565 (Linking)
VOLUME: 12
PAGES: 1400782
PLACE OF PUBLICATION: Switzerland
ABSTRACT:
BACKGROUND: To identify determinants influencing Canadian parents' decision not to vaccinate their children aged 6 months to 17 years against seasonal influenza. METHODS: Data from the 2022 Childhood COVID-19 Immunization Coverage Survey, a national survey of approximately 10,500 Canadian parents/guardians and their children, was analyzed. The survey examined influenza vaccine coverage, parental perspectives on vaccines, reasons for hesitancy, and factors influencing immunization. Socio-demographic characteristics, including ethnicity, household income, working sector, educational attainment, and prevalence of chronic medical conditions among children were considered. Historical vaccine uptake and the impact of the COVID-19 pandemic on immunization decisions were also reviewed. Key determinants of non-vaccination in the 2021-2022 influenza season were analyzed using multivariable logistic regression, with a statistical significance level set at p-value <0.05. RESULTS: 70% of children aged 6 months to 17 years did not receive the seasonal influenza vaccine. Key predictors for non-vaccination included: residing in rural settings (aOR 1.35, 95% CI 1.13-1.60), parental education attainment of less than high school (aOR 2.48, 95% CI 1.24-4.97), and the absence of chronic medical conditions in children (aOR 1.60, 95% CI 1.34-1.91). Other strong predictors included lower household income; deterrence due to the COVID-19 pandemic; and parental hesitancy stemming from concerns about the vaccine's safety, effectiveness, and by beliefs that their child was not at risk of contracting the influenza or severe consequences from the infection. CONCLUSION: This research underscores pivotal determinants of parental decisions not to vaccinate their children against seasonal influenza and sheds light on the impact of the COVID-19 pandemic. The results highlight the importance of addressing safety concerns and providing clear information to alleviate hesitancy.
COPYRIGHT INFORMATION: Copyright (c) 2024 Alami, Dave, Uhlik, Ebrahim, Krewski and Laroche.
LANGUAGE: eng
DATE OF PUBLICATION: 2024
DATE OF ELECTRONIC PUBLICATION: 20240605
DATE COMPLETED: 20240621
DATE REVISED: 20240622
MESH DATE: 2024/06/21 06:43
EDAT: 2024/06/21 06:42
STATUS: MEDLINE
PUBLICATION STATUS: epublish
LOCATION IDENTIFIER: 10.3389/fpubh.2024.1400782 [doi] 1400782
OWNER: NLM

Related RSI Experts

Daniel Krewski

Chief Risk Scientist

Dr. Daniel Krewski is Chief Risk Scientist and co-founder of Risk Sciences International (RSI), a firm established in 2006 to bring evidence-based, multidisciplinary expertise to the challenge of understanding, managing, and communicating risk. As RSI’s inaugural CEO and long-time scientific...
Read More about Daniel Krewski